Re: Effect of erythropoietin on kidney allograft survival: Early use after transplantation

Iranian Journal of Kidney Diseases

Volumn 7, Issue 4, 2013, Pages 332-333

  Baradaran, Azar ^a   Nasri, Hamid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; NONHUMAN; POSTOPERATIVE PERIOD; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

EID: 84880723535     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. Yasari F, Nafar M, Alipour Abdei B, et al. Effect of erythropoietin on kidney allograft survival: early use after transplantation. Iran J Kidney Dis. 2012;6:44-8.
2. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, et al. Erythropoietin ameliorates gentamicin-induced renal toxicity: A biochemical and histopathological study. J Nephropathol. 2012;1:109-16.
3. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathol. 2012;1:81-2.
4. Nematbakhsh M, Ashrafi F, Pezeshki Z, et al. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: which one is the first observation as side effect of cisplatin-induced toxicity in animal model? J Nephropathol. 2012;1:190-3.
5. Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci. 2012;17:621-5.
6. Tavafi M. Inhibition of gentamicin - induced renal tubular cell necrosis. J Nephropathol. 2012;1:83-6.
7. Nemati E, Abbaszadeh S. Re: effect of erythropoietin on kidney allograft survival: early use after transplantation. Iran J Kidney Dis. 2012;6:227.
8. Gobe GC, Morais C, Vesey DA, Johnson DW. Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney. J Nephropathol. 2013;2:154-65.
9. Alhamad T, Blandon J, Meza AT, Bilbao JE, Hernandez GT. Acute kidney injury with oxalate deposition in a patient with a high anion gap metabolic acidosis and a normal osmolal gap. J Nephropathol. 2013;2:139-43.
10. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic Kidney Disease in Children: A report from a tertiary care center over 11 years. J Nephropathol. 2012;1:177-82.
11. Fliser D, Bahlmann FH, Haller H. EPO: renoprotection beyond anemia correction. Pediatr Nephrol. 2006;21:1785-9.
12. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathol. 2012;1:101-8.
13. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012;1:162-3.
14. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathol. 2012;1:123-5.
15. Kam-Tao Li PK, Burdmann EA, Mehta RL. Acute kidney injury: global health alert. J Nephropathol. 2013;2:90-7.